Peptide Synthesis: SPPS, Recombinant & Modern Methods

Solid-Phase Peptide Synthesis (SPPS)

The dominant method for laboratory-scale peptide production is solid-phase peptide synthesis, pioneered by Bruce Merrifield in 1963 (Nobel Prize in Chemistry, 1984).

In SPPS, the C-terminal amino acid is anchored to an insoluble resin bead. Subsequent amino acids are added one by one in the N-to-C direction. Each cycle involves:

Deprotection — Removal of the N-terminal protecting group (commonly Fmoc or Boc).
Coupling — Activation and addition of the next protected amino acid using coupling reagents (e.g., HBTU, HATU, DIC/HOBt).
Washing — Removal of excess reagents.

After the desired sequence is assembled, the peptide is cleaved from the resin, usually with strong acid (TFA), and side-chain protecting groups are simultaneously removed.

Solid-phase synthesis builds peptides on resin beads, adding one residue at a time.

SPPS Cycle (simplified)

Fmoc vs Boc Chemistry

Fmoc (9-fluorenylmethyloxycarbonyl) — Milder conditions, base-labile deprotection. Preferred for most modern syntheses.
Boc (tert-butyloxycarbonyl) — Acid-labile, historically important but requires harsher HF cleavage. Still used for certain difficult sequences.

Liquid-Phase and Solution Synthesis

Classical solution-phase methods couple protected amino acids in solution. While more labor-intensive for long sequences, they remain useful for large-scale production of short peptides and for certain modifications that are incompatible with solid supports.

Recombinant Production

For longer peptides or those requiring complex post-translational modifications, biological expression systems are used:

E. coli — Fast, inexpensive, but limited post-translational modification capability.
Yeast (Pichia, Saccharomyces) — Better glycosylation and folding for some eukaryotic peptides.
Mammalian cell lines — Used for complex therapeutic peptides needing authentic modifications.

The target sequence is typically expressed as part of a larger fusion protein, then cleaved and purified.

Recombinant production expresses peptides in engineered host organisms via fermentation.

Chemical Ligation Techniques

Native Chemical Ligation (NCL) and related methods allow the assembly of very long peptides and small proteins from shorter synthetic fragments. This has enabled total chemical synthesis of proteins over 100 amino acids.

Purification and Characterization

Crude synthetic peptides are typically purified by reverse-phase HPLC. Final products are characterized by:

Mass spectrometry (MALDI-TOF or ESI-MS)
Analytical HPLC (purity >95% is common for research grade)
Amino acid analysis or sequencing (Edman or MS/MS)
CD spectroscopy or NMR for secondary structure

Modern Advances

Current research focuses on:

Automated and continuous-flow synthesizers
Microwave-assisted coupling for faster, higher-yield reactions
Greener solvents and reagents
One-pot ligation and cyclization strategies
Cell-free expression systems

Practical Considerations

When planning a synthesis, researchers consider sequence length, hydrophobicity, difficult residues (e.g., multiple prolines, beta-branched amino acids), and the need for specific modifications (cyclization, fluorescent labels, D-amino acids, PEGylation).

Common Peptide Modifications

Cyclization — Head-to-tail or disulfide for stability.
PEGylation — Improves solubility and half-life.
Stapling — Hydrocarbon bridges for helical peptides.
Lipidation — Fatty acids for membrane association or oral delivery.
Fluorescent labels — For imaging and assays.